Saroglitazar is a Dual PPAR α/γ Agonist for Diabetic Dyslipidemia (DD) and NAFLD Research
PPAR is a ligand activated transcription factor of the nuclear hormone receptor superfamily. Meanwhile, it contains the following three subtypes: PPAR-α、 PPAR-γ And PPAR-β/δ. PPAR-α Activation can reduce triglyceride levels…